From: Immunotherapy Bridge 2020 and Melanoma Bridge 2020: meeting abstracts
Pts Code | Age (yrs) | Phenotype | Cytogenetics | Bone Marrow | Peripheral Blood |
---|---|---|---|---|---|
ALL#02P | 1.5 | B-cell ALL common | Normal | Yes | Â |
ALL#03P | 1.5 | B-cell ALL common | Complex karyotype | Yes | Â |
ALL#05P | 15 | B-cell ALL common | Normal | Yes | Â |
ALL#09P | - | T-cell ALL | Normal | Yes | Â |
ALL#10P | 8 | B-cell ALL common | Normal | Yes | Yes |
ALL#11P | 12 | B-cell ALL common | Normal | Yes | Yes |
ALL#12P | 5 | Pro-B ALL | Normal | Â | Yes |
ALL#13P | 11 | B-cell ALL common | t(1;19) | Â | Yes |
ALL#14P | 12 | Pro-B ALL | Normal | Â | Yes |
ALL#15P | 7 | T-cell ALL | Normal | Â | Yes |
ALL#16P | 16 | B-cell ALL common | Normal | Yes | Yes |
ALL#17P | 15 | T-cell ALL | Normal | Yes | Â |
ALL#18P | 1.5 | B-cell ALL Common | Normal | Yes | Â |
ALL#19P | 3 | B-cell ALL Common | t(12;21) | Â | Yes |
ALL#20P | 5 | B-cell ALL Common | t(12;21) | Â | Yes |
ALL#21P | 14 | ALL B Mature | t(8;14) | Yes | Â |